Transition of blaOXA-58-like to blaOXA-23-like in acinetobacter baumannii clinical isolates in Southern China: An 8-year study

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Wu, Weiyuan ^a   He, Yi ^b   Lu, Jian ^b   Lu, Yuemei ^a   Wu, Jinsong ^a   Liu, Yingxia ^b  

^a SHENZHEN PEOPLE'S HOSPITAL   (China)

^b SHENZHEN THIRD PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPENEM; MEROPENEM; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE OXA-23, ACINETOBACTER BAUMANNII; CARBAPENEMASE; ISOENZYME; THIENAMYCIN DERIVATIVE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BETA LACTAMASE 23 LIKE GENE; BETA LACTAMASE 40 LIKE GENE; BETA LACTAMASE 51 LIKE GENE; BETA LACTAMASE 58 LIKE GENE; CHINA; CLONAL VARIATION; CONTROLLED STUDY; GENE IDENTIFICATION; GENE INSERTION; GENE INSERTION SEQUENCE; GENE LOCATION; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHASE TRANSITION; POLYMERASE CHAIN REACTION; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; ACINETOBACTER INFECTIONS; BACTERIUM CONJUGATION; CELL CLONE; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION; GENETICS; HOSPITAL; HUMAN; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PLASMID; RETROSPECTIVE STUDY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHINA; CLONE CELLS; CONJUGATION, GENETIC; GENE EXPRESSION; HOSPITALS; HUMANS; IMIPENEM; INTENSIVE CARE UNITS; ISOENZYMES; PLASMIDS; RETROSPECTIVE STUDIES; THIENAMYCINS;

EID: 84945232027     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137174     Document Type: Article

References (35)

1. OXA-23 carbapenemase gene of Acinetobacterbaumannii. Emerg Infect Dis. 2010; 16:35-40. doi: 10.3201/eid1601.090852 PMID: 20031040
2. Higgins PG, Lehmann M, Seifert H. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2010; 35:305-314.
3. Higgins PG, Pérez-Llarena FJ, Zander E, Fernández A, Bou G, Seifert H. OXA-235, a novel class D p-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. 2013; 57:2121-2126. doi: 10.1128/AAC.02413-12 PMID: 23439638
4. Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D p-Lactamases. Antimicrob Agents Chemother. 2010; 54:24-38. doi: 10.1128/AAC.01512-08 PMID: 19721065
5. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett. 2006; 258:72-77. PMID: 16630258
6. OXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother. 2006; 50:1442-1448. PMID: 16569863
7. OXA-58 genes in Acinetobactergenospecies 3. J Antimicrob Chemother. 2010; 65:1586-1588. doi: 10.1093/jac/dkq180 PMID: 20542900
8. OXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii. Antimicrob Agents Chemother. 2008; 52:2573-2580. doi: 10.1128/AAC.00393-08 PMID: 18443121
9. OXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother. 2007; 51:1530-1533. PMID: 17220422
10. Minandri F, DArezzo S, Antunes LC, Pourcel C, Principe L, Petrosillo N, et al. Evidence of diversity among epidemiologically related carbapenemase-producing Acinetobacter baumannii strains belonging to international clonal lineage II. J Clin Microbiol. 2012; 50:590-597. doi: 10.1128/JCM.05555-11 PMID: 22205821
11. Wang X, Qiao F, Yu R, Gao Y, Zong Z. Clonal diversity of Acinetobacter baumannii clinical isolates revealed by a snapshot study. BMC Microbial. 2013; 13:234. doi: 10.1186/1471-2180-13-234
12. Fu Y, Zhou J, Zhou H, Yang Q, Wei Z, Yu Y, et al. Wide dissemination of OXA-23-producing carbape-nem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. J Antimicrob Chemother. 2010; 65: 644-650. doi: 10.1093/jac/dkq027 PMID: 20154023
13. OXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006; 44:2974-2976. PMID: 16891520
14. Turton JF, Shah J, Ozongwu C, Pike R. Incidence of Acinetobacter species otherthan A baumannii among clinical isolates of Acinetobacter evidence for emerging species. J Clin Microbiol. 2010; 48:1445-1449. doi: 10.1128/JCM.02467-09 PMID: 20181894
15. Wang J, Ruan Z, Feng Y, Fu Y, Jiang Y, Wang H, et al. Species distribution of clinical Acinetobacter isolates revealed by different identification techniques. PLoS One 2014; 9(8):e104882. doi: 10.1371/journal.pone.0104882 PMID: 25120020
16. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 24th informational supplement. M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA; 2014.
17. Ellington MJ, Kistler J, Livermore DM, Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-p-lactamases. J Antimicrob Chemother. 2007; 59:321-322. PMID: 17185300
18. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. Multiplex PCRforgenes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006; 27:351-353. PMID: 16564159
19. Robledo IE, Aquino EE, Santé MI, Santana JL, Otero DM, León CF, et al. Detection of KPC in Acinetobacterspp. in Puerto Rico. Antimicrob Agents Chemother. 2010; 54:1354-1357. doi: 10.1128/AAC. 00899-09 PMID: 20038618
20. Hunter SB, Vauterin P, Lambert-Fair MA, Duyne MSV, Kubota K, Graves L, et al. Establishment of a Universal Size Standard Strain for Use with the PulseNet Standardized Pulsed-Field Gel Electrophoresis Protocols: Converting the National Databases to the New Size Standard. J Clin Microbiol. 2005; 43:1045-1050. PMID: 15750058
21. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, et al. Standardization and Interlaboratory Reproducibility Assessment of Pulsed-Field Gel Electrophoresis-Generated Fingerprints of Acinetobacterbaumannii. J Clin Microbiol. 2005; 43:4328-4335. PMID: 16145073
22. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995; 33:2233-2239. PMID: 7494007
23. Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodriguez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacterbaumannii. J Clin Microbiol. 2005; 43:4382-4390. PMID: 16145081
24. Zhou H, Yang Q, Yu YS, Wei ZQ, Li LJ. Clonal spread of imipenem-resistant Acinetobacterbaumannii among different cities of China. J Clin Microbiol. 2007; 45:4054-4057. PMID: 17942662
25. Wang H, Guo P, Sun H, Wang H, Yang Q, Chen M, et al. Molecular epidemiology of clinical isolates of carbapenem-resistantAcinetobacterspp. from Chinese hospitals. Antimicrob Agents Chemother. 2007; 51: 4022-4028 PMID: 17846127
26. DArezzo S, Principe L, Capone A, Petrosillo N, Petrucca A, Visca P. Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacterbaumannii lineage causing multiple outbreaks in central Italy. J Antimicrob Chemother. 2011; 66:54-61. doi: 10.1093/jac/dkq407 PMID: 21088019
27. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 23rd informational supplement. M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA; 2013.
28. Coelho J, Woodford N, Afzal-Shah M, Livermore D. Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob Agents Chemother. 2006; 50: 756-758. PMID: 16436738
29. OXA-58 expression in Acinetobacterbaumannii. Antimicrob Agents Chemother. 2011; 55:917-920. doi: 10.1128/AAC.00491-10 PMID: 21098239
30. Heritier C, Poirel L, Lambert T, Nordmann P. Contribution of acquired carbapenem-hydrolyzing oxacilli-nases to carbapenem resistance in Acinetobacterbaumannii. Antimicrob Agents Chemother. 2005; 49: 3198-3202. PMID: 16048925
31. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacterbaumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006; 12: 826-836. PMID: 16882287
32. Higgins PG, Wisplinghoff H, Stefanik D, Seifert H. Selection of topoisomerase mutations and overex-pression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii. J Antimicrob Chemother. 2004; 54: 821-823. PMID: 15355942
33. 58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. 2007; 51: 2324-2328. PMID: 17438042
34. OXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis. 2010; 16:35-40. doi: 10.3201/eid1601.090852 PMID: 20031040
35. Nemec A, Krízová L, Maixnerová M, Diancourt L, van der Reijden TJ, Brisse S, et al. Emergence of carbapenem resistance in Acinetobacterbaumannii in the Czech Republic is associated with the spread of multidrug resistant strains of European clone II. J Antimicrob Chemother. 2008; 62: 484-489. doi: 10.1093/jac/dkn205 PMID: 18477708